Tuesday, February 11, 2025 12:02:48 PM
FeMike first reaction post.
Six months from approval.
FeMike second reaction post
Four months from approval.
Anyway, that wasn’t answering Doc Lee’s original comment. His comment is that he’d be extremely disappointed if she hasn’t been addressing price with NICE.
So, you may have run out a possible timeline, not certain, but the reality is NWBO started around August by hiring two experts to begin stage one of reimbursement preparations.
Upon (hopefully) approval, I would be disappointed if her reimbursement planning and action hasn’t been up to snuff since her last communication in the 10q on these matters, but instead, I expect she’ll present a very robust history and plan that began last summer and is in motion.
We’ll see how this is all laid out.
Six months from approval.
FeMike second reaction post
Four months from approval.
Anyway, that wasn’t answering Doc Lee’s original comment. His comment is that he’d be extremely disappointed if she hasn’t been addressing price with NICE.
So, you may have run out a possible timeline, not certain, but the reality is NWBO started around August by hiring two experts to begin stage one of reimbursement preparations.
Upon (hopefully) approval, I would be disappointed if her reimbursement planning and action hasn’t been up to snuff since her last communication in the 10q on these matters, but instead, I expect she’ll present a very robust history and plan that began last summer and is in motion.
We’ll see how this is all laid out.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
